HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ulgiati, D. Articles by Holers, V. M. Search for Related Content PubMed PubMed Citation Articles by Ulgiati, D. Articles by Holers, V. M.

Functional Analysis of the Human Complement Receptor 2 (CR2/CD21) Promoter: Characterization of Basal Transcriptional Mechanisms¹

Daniela Ulgiati^*, Christine Pham and V. Michael Holers^2,*

^* Departments of Immunology and Medicine, Division of Rheumatology, University of Colorado Health Sciences Center, Denver, CO 80262; and Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110

Human complement receptor (CR) type 2 (CR2/CD21) is a 145-kDa membrane protein encoded within the regulators of complement activation gene cluster localized on human chromosome 1q32. Understanding the mechanisms that regulate CR2 expression is important because CR2 is expressed during specific stages of B cell development, and several lines of evidence suggest a role for altered CR2 function or expression in a number of autoimmune diseases. Additionally, even modest changes in CR2 expression are likely to affect relative B cell responses. In this study we have delineated the transcriptional requirements of the human CR2 gene. We have studied the human CR2 proximal promoter and identified sites important for controlling the level of transcription in CR2-expressing cells. We have determined that four functionally relevant sites lie within very close proximity to the transcriptional initiation site. These sites bind the transcription factors USF1, an AP-2-like transcription factor, and Sp1.

This article has been cited by other articles:

				I. Debnath, K. M. Roundy, J. J. Weis, and J. H. Weis Defining In Vivo Transcription Factor Complexes of the Murine CD21 and CD23 Genes J. Immunol., June 1, 2007; 178(11): 7139 - 7150. [Abstract] [Full Text] [PDF]

				H. Wu, S. A. Boackle, P. Hanvivadhanakul, D. Ulgiati, J. M. Grossman, Y. Lee, N. Shen, L. J. Abraham, T. R. Mercer, E. Park, et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus PNAS, March 6, 2007; 104(10): 3961 - 3966. [Abstract] [Full Text] [PDF]

				H.-g. Hu, H. Illges, C. Gruss, and R. Knippers Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes Int. Immunol., June 1, 2005; 17(6): 789 - 796. [Abstract] [Full Text] [PDF]

				M. Tolnay, L. A. Vereshchagina, and G. C. Tsokos NF-{kappa}B Regulates the Expression of the Human Complement Receptor 2 Gene J. Immunol., December 1, 2002; 169(11): 6236 - 6243. [Abstract] [Full Text] [PDF]